Us Renal Care Tarrant Dialysis Arlington is a medicare approved dialysis facility center in Arlington, Texas and it has 24 dialysis stations. It is located in Tarrant county at 203 W Randol Mill Rd, Arlington, TX, 76011. You can reach out to the office of Us Renal Care Tarrant Dialysis Arlington at (817) 275-7787. This dialysis clinic is managed and/or owned by Us Renal Care, Inc.. Us Renal Care Tarrant Dialysis Arlington has the following ownership type - Profit. It was first certified by medicare in June, 1986. The medicare id for this facility is 452580 and it accepts patients under medicare ESRD program.
| Name | Us Renal Care Tarrant Dialysis Arlington |
|---|---|
| Location | 203 W Randol Mill Rd, Arlington, Texas |
| No. of Dialysis Stations | 24 |
| Medicare ID | 452580 |
| Managed By | Us Renal Care, Inc. |
| Ownership Type | Profit |
| Late Shifts | No |
| 203 W Randol Mill Rd, Arlington, Texas, 76011 | |
| (817) 275-7787 | |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
| NPI Number | 1942256466 |
| Organization Name | Us Renal Care Tarrant Dialysis Arlington |
| Doing Business As | Usrc Tarrant Lp |
| Address | 203 W Randol Mill Rd Arlington, Texas, 76011 |
| Phone Number | (817) 275-7787 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 50% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 10% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 40% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 37% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 31% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 32% | 14% |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 55% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 17% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 28% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 56% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 31% | 12% |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 72% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 28% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 54% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 17% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 29% | 12% |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
| Dialysis patients with Hemoglobin data | 64 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 14 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 136 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 1165 |
| Percentage of adult patients getting regular hemodialysis at the center | 97 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Us Renal Care Tarrant Dialysis Arlington with elevated calcium levels.
| Patients with hypercalcemia | 138 |
| Hypercalcemia patient months | 1193 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 141 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 23 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 32 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 14 |
| Patients with Serumphosphor greater than 7 mg/dL | 22 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 105 |
| Patient months included in arterial venous fistula and catheter summaries | 878 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 73 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 20 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 124 |
| Hospitalization Rate in facility | 174.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 278.8 |
| Hospitalization Rate: Lower Confidence Limit | 117 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
The rate of readmission show you whether patients who were being treated regularly at Us Renal Care Tarrant Dialysis Arlington were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 25.2 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 32.3 |
| Readmission Rate: Lower Confidence Limit | 19 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Us Renal Care Tarrant Dialysis Arlington get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .19 (Better than Expected) |
| SIR: Upper Confidence Limit | .61 |
| SIR: Lower Confidence Limit | .03 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Us Renal Care Tarrant Dialysis Arlington's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 103 |
| Transfusion Rate in facility | 47 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 89.6 |
| Transfusion Rate: Lower Confidence Limit | 26.7 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
The rate of mortality show you whether patients who were being treated regularly at Us Renal Care Tarrant Dialysis Arlington lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 613 |
| Mortality Rate in facility | 12.3 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 16.4 |
| Mortality Rate: Lower Confidence Limit | 9 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago
Us Renal Care Tarrant Dialysis Arlington Location: 203 W Randol Mill Rd, Arlington, Texas, 76011 Phone: (817) 275-7787 |
South Arlington Dialysis Center Location: 3415 S Cooper Street, Arlington, Texas, 76015 Phone: (817) 465-8585 |
Ameri-Tech Kidney Center-Arlington Llc Location: 1138 S Bowen Road, Arlington, Texas, 76013 Phone: (817) 265-7115 |
News Archive
The Wall Street Journal recently published an article debunking—and proving—several myths regarding the eyes. Dr. William Boothe weighs in on this important conversation, as he believes that proper eye health can only be achieved if individuals understand how their eyes work, and how to take care of them.
Using a succession of biological mechanisms, Sandia National Laboratories researchers have created linkages of polymer nanotubes that resemble the structure of a nerve, with many out-thrust filaments poised to gather or send electrical impulses.
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention, a procedure to clear blocked arteries, in a trial being presented at the American College of Cardiology's 67th Annual Scientific Session.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that it has submitted a Phase IIb protocol to the U.S. Food and Drug Administration (FDA) for the clinical study of Serdaxin for the treatment of major depressive disorder (MDD).
A new Eljay LLC analysis of the nation's Medicaid financing system projecting states will cumulatively underfund the actual cost of providing quality long term care by nearly $4.7 billion for 2009, and finds seniors in the states of New York, Illinois, Ohio, Texas, New Jersey, Pennsylvania, Massachusetts, Florida, California and Wisconsin will bear the brunt of the underfunding burden at a time when these states and many others are already suffering from rising pressure on state Medicaid budgets.
› Verified 5 days ago